ERNA Earnings

Quarterly EPS
$-56.38
Q4 2024
$-57.76
Q1 2025
$-15.19
Q2 2025
$-3.77
Q3 2025
$-4.56
Q4 2025
$-6.95
Q1 2026
$-3.40
Q2 2026
$-1.89
Q3 2026
Latest RevenueN/A
Latest Net Income-2941000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$1.890-2941000—+49.9%
Q2 2026-$3.400-4009000—+77.6%
Q1 2026-$6.950-5506000—+88.0%
Q4 2025-$4.560-1502000-100.0%+91.9%
Q3 2025-$3.770-1240000-100.0%+99.8%
Q2 2025-$15.190-3139000-100.0%+96.0%
Q1 2025-$57.760-8202000-100.0%+87.5%
Q4 2024-$56.381.0K-5759000-94.1%+86.8%
Q3 2024-$1,842.50487.0K-26604000——
Q2 2024-$383.5047.0K-5529000——
Q1 2024-$461.2547.0K-6647000——
Q4 2023-$426.5817.0K-6212000——
Ernexa Therapeutics (ERNA) — Earnings